Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway Lipid Signaling Lipid Phosphatases

Anti-LCLAT1 antibody (ab122197)

Anti-LCLAT1 antibody (ab122197)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Rabbit polyclonal to LCLAT1
  • Suitable for: ICC, IHC-P
  • Reacts with: Human
  • Isotype: IgG

You may also be interested in

Product image
Anti-INPP1 antibody (ab97912)
Recombinant Human INPP5A protein (ab199597)
Product image
Anti-INPP5B antibody (ab238909)
Product image
Anti-LPGAT1 antibody (ab70076)

Overview

  • Product name

    Anti-LCLAT1 antibody
    See all LCLAT1 primary antibodies
  • Description

    Rabbit polyclonal to LCLAT1
  • Host species

    Rabbit
  • Tested applications

    Suitable for: ICC, IHC-Pmore details
  • Species reactivity

    Reacts with: Human
  • Immunogen

    antigen sequence, corresponding to amino acids 231-307 (LHPRTTGFTF VVDRLREGKN LDAVHDITVA YPHNIPQSEK HLLQGDFPRE IHFHVHRYPI DTLPTSKEDL QLWCHKR) of Human LCLAT1.

    Run BLAST with BLAST the sequence with ExPASy Run BLAST with BLAST the sequence with NCBI
  • Positive control

    • IHC-P: Human heart muscle, duodenum, testis, and fallopian tube tissues; ICC: Human cell line A-431.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
  • Storage buffer

    pH: 7.20
    Preservative: 0.02% Sodium azide
    Constituents: 40% Glycerol (glycerin, glycerine), 59% PBS
  • Concentration information loading...
  • Purity

    Immunogen affinity purified
  • Clonality

    Polyclonal
  • Isotype

    IgG
  • Research areas

    • Signal Transduction
    • Signaling Pathway
    • Lipid Signaling
    • Lipid Phosphatases
    • Metabolism
    • Pathways and Processes
    • Mitochondrial Metabolism
    • Mitochondrial markers
    • Metabolism
    • Pathways and Processes
    • Metabolic signaling pathways
    • Lipid and lipoprotein metabolism
    • Lipid metabolism

Images

  • Immunocytochemistry - Anti-LCLAT1 antibody (ab122197)
    Immunocytochemistry - Anti-LCLAT1 antibody (ab122197)

    Immunocytochemistry/immunofluorescence analysis of human cell line A-431 shows labelling LCLAT1 with ab122197 at 2 µg/mL.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human heart muscle tissue labelling LCLAT1 with ab122197 at 1/200 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human duodenum tissue labelling LCLAT1 with ab122197 at 1/200 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human testis tissue labelling LCLAT1 with ab122197 at 1/200 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)
    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LCLAT1 antibody (ab122197)

    Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human fallopian tube tissue labelling LCLAT1 with ab122197 at 1/200 dilution. Heat mediated antigen retrieval performed with citrate buffer pH 6 before commencing with IHC staining protocol.

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-LCLAT1 antibody (ab122197)

  •  
  • Product image

    Anti-LCLAT1 antibody (ab153987)

    Applications: WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-CD137 antibody [EPR23218-111] (ab243648)

  •  
  • Product image

    Anti-GLP1 antibody [EPR4042-407] (ab111125)

  •  
  • Product image

    Anti-VEGFA antibody [EPR21220] (ab232858)

  •  
  • Product image

    Anti-AGXT antibody [EPR13232-59] (ab178699)

  •  
  • Product image

    Anti-Cathepsin K antibody [C1] (ab239506)

  •  
  • Product image

    Anti-SYT2 antibody (ab113545)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.